Who is sponsoring NCT07175623?

NCT07175623 is sponsored by Konya City Hospital.

What condition does NCT07175623 study?

NCT07175623 studies Neuromuscular Block, Residual, Pain Management, Postoperative Nausea.

What drugs are being tested in NCT07175623?

Interventions: Methyl Prednisolone (MP), Dexamethasone (0.2 mg/kg), Saline (0.9% NaCl).

What is the status of NCT07175623?

NCT07175623 is currently COMPLETED.

Last reviewed 2025-12-29 · How we verify

Methylprednisolone vs Dexamethasone Interaction With Sugammadex in Pediatric Patients

NCT07175623 NA COMPLETED

This randomized controlled trial aims to compare the interaction of methylprednisolone and dexamethasone with sugammadex in pediatric patients undergoing adenoidectomy and/or tonsillectomy. The primary objective is to evaluate the effect of these corticosteroids on the reversal time of rocuronium-induced neuromuscular block by sugammadex. Secondary outcomes include postoperative pain, nausea and vomiting, extubation time, and adverse events. Eligible participants are children aged 5 to 12 years, ASA I-II, scheduled for elective surgery under general anesthesia. The study is designed as a triple-blind, parallel-group trial with three arms: methylprednisolone, dexamethasone, and placebo.

Details

Lead sponsor	Konya City Hospital
Phase	NA
Status	COMPLETED
Enrolment	60
Start date	Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Dec 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Neuromuscular Block, Residual
Pain Management
Postoperative Nausea

Interventions

Methyl Prednisolone (MP)
Dexamethasone (0.2 mg/kg)
Saline (0.9% NaCl)

Countries

Turkey (Türkiye)